{"id":"W4415295624","doi":"10.1016/j.annonc.2025.09.018","title":"Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"William Osler Health System","funders":"Foundation Medicine; Genentech; Ipsen; BeiGene; Novocure; Regeneron Pharmaceuticals; Gilead Sciences; Daiichi Sankyo Europe; Sanofi; Incyte; F. Hoffmann-La Roche; Roche; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Alectinib; Crizotinib; Overall survival; Lung; Phases of clinical research; Standard of care","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005807695,0.00114773,0.002082189,0.0003639253,0.0001860705,0.0009772158,0.0006655481,0.0005562015,0.001518382],"category_scores_gemma":[0.002519089,0.0002865285,0.003682001,0.0003893677,0.0004442315,0.0004748165,0.0004629686,0.001725987,0.0002841715],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009326151,"about_ca_system_score_gemma":0.001028306,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008197774,"about_ca_topic_score_gemma":0.002679961,"domain_scores_codex":[0.9983919,0.001112679,0.00007902584,0.0001423861,0.000162101,0.0001117999],"domain_scores_gemma":[0.9983143,0.0005071491,0.0005199012,0.0001512494,0.0001202601,0.000387143],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9134195,0.003211229,0.01486417,0.0007908819,0.009578378,0.00007024338,0.00008927911,0.004121896,0.005018989,0.0002073781,0.002243852,0.04638426],"study_design_scores_gemma":[0.6367477,0.2467096,0.08618896,0.0001490507,0.0155532,0.0003959132,0.00009545831,0.0061327,0.002556034,0.0005490707,0.004860311,0.00006199494],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9835849,0.01076551,0.0008095358,0.0004536631,0.00009798996,0.0006666174,0.001521486,0.00005653948,0.002043796],"genre_scores_gemma":[0.9928774,0.002153417,0.0006499065,0.0003181355,0.0001056292,0.0003793629,0.002607049,0.00001753934,0.0008915712],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005807695,"threshold_uncertainty_score":0.03071439,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04998713965319557,"score_gpt":0.4563106273006205,"score_spread":0.4063234876474249,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}